HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uterine Neoplasms (Uterine Cancer)

Tumors or cancer of the UTERUS.
Also Known As:
Uterine Cancer; Cancer of the Uterus; Neoplasms, Uterine; Neoplasms, Uterus; Uterus Cancer; Uterus Neoplasms; Cancer, Uterine; Cancer, Uterus; Cancers, Uterine; Cancers, Uterus; Neoplasm, Uterine; Neoplasm, Uterus; Uterine Cancers; Uterine Neoplasm; Uterus Cancers; Uterus Neoplasm; Cancer of Uterus
Networked: 1516 relevant articles (51 outcomes, 144 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Diarrhea
3. Lung Neoplasms (Lung Cancer)
4. Endometriosis
5. Breast Neoplasms (Breast Cancer)

Experts

1. Wright, Jason D: 23 articles (01/2022 - 09/2007)
2. Hershman, Dawn L: 14 articles (01/2022 - 07/2013)
3. Hou, June Y: 13 articles (01/2022 - 02/2015)
4. Tergas, Ana I: 12 articles (12/2020 - 02/2015)
5. Ananth, Cande V: 12 articles (09/2019 - 07/2013)
6. Neugut, Alfred I: 10 articles (09/2019 - 07/2013)
7. Chen, Ling: 9 articles (01/2022 - 05/2014)
8. Sood, Anil K: 9 articles (10/2021 - 04/2014)
9. Kapp, Daniel S: 8 articles (01/2021 - 06/2007)
10. Havrilesky, Laura J: 7 articles (01/2022 - 11/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Uterine Neoplasms:
1. SeleniumIBA
2. Doxorubicin (Adriamycin)FDA LinkGeneric
3. Estrogens (Estrogen)FDA Link
4. Oral ContraceptivesIBA
12/01/1995 - "High dose oral contraceptives have generally been replaced by low dose formulations and, subsequently, most cardiovascular risks have been reduced and a protection against ovarian and uterine cancers has been consistently demonstrated. "
05/01/1992 - "The low dose oral contraceptive (OC) is the only drug which extends life and prevents ovarian and uterine cancer. "
11/01/2003 - "Women that were married, mothers, on menopause, with a family history of cancer, uterine fibroma, past users of oral contraceptives were more likely to having performed Ma, but not US. "
12/01/1975 - "It is emphasized that, in order to obtain a safe and effective treatment, the prescription of oral contraceptives must follow certain stringent rules: a careful initial examination of the patient is necessary to detect previous cardiovascular, diabetic, or hyperlipemic conditions; clinical and gynecological examinations to detect signs of cancer of the uterus and breasts should also be made before making a decision; careful laboratory studies, especially concerning fat and carbohydrate metabolism, should be performed during treatment; the contraceptive drug should be selected among those containing the lowest doses. "
04/07/1972 - "Oral contraceptives are contraindicated in cases presenting a history of thromboembolism, phlebitis, cerebral apoplexy; sickle cell anemia, which indicates a predisposition to thromboembolic accidents; serious liver disease or recent hepatitis; serious heart disease; hormone-dependent neoplasia (breast cancer); predisposition to uterine cancer; erythematous lupus; metorrhagia of unknown origin; psychic disorders, especially of a depressive type. "
5. Progesterone Receptors (Progesterone Receptor)IBA
6. TamoxifenFDA LinkGeneric
7. Hormones (Hormone)IBA
8. Biomarkers (Surrogate Marker)IBA
9. Contraceptive Agents (Contraceptives)IBA
01/01/1986 - "[Analysis of the association between previous contraceptive use and the incidence of cervico-uterine cancer in women from the northern and eastern area of Santiago]."
01/01/2020 - "This article will describe the specific mechanisms of action and summarize the available data documenting how hormonal contraceptives can prevent ovarian and uterine cancer and be used to treat women with a variety of gynecological and nongynecological conditions such as endometriosis, uterine fibroids, heavy menstrual bleeding, polycystic ovary syndrome, acne, and migraines. "
12/01/1975 - "It is emphasized that, in order to obtain a safe and effective treatment, the prescription of oral contraceptives must follow certain stringent rules: a careful initial examination of the patient is necessary to detect previous cardiovascular, diabetic, or hyperlipemic conditions; clinical and gynecological examinations to detect signs of cancer of the uterus and breasts should also be made before making a decision; careful laboratory studies, especially concerning fat and carbohydrate metabolism, should be performed during treatment; the contraceptive drug should be selected among those containing the lowest doses. "
01/01/2016 - "Using the Femilis® 60 LNG-IUS releasing 20 µg of levonorgestrel/day, the following studies were conducted: an open, prospective noncomparative contraceptive study, an MBL study, a perimenopausal study, a study for the treatment of endometrial hyperplasia, and early cancer of the uterus, a residue study. "
03/01/1978 - "Medroxyprogesterone (Depo-Provera), a progesterone used as an injection for 1) treating cancer of the uterus, and 2) an injectable contraceptive, is approved by 69 countries, manufactured in at least 6 countries, and is distributed to 42 countries by the International Planned Parenthood Federation. "
10. Selective Estrogen Receptor Modulators (SERM)IBA

Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Drug Therapy (Chemotherapy)
4. Lymph Node Excision (Lymph Node Dissection)
5. Immunotherapy